Efficacy of Artemisia Pollen Specific Allergen Immunotherapy

Clinical trial NCT05318157 · UNKNOWN

Trial details

NCT number: NCT05318157
Sponsor: Beijing Tongren Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Allergic Rhinitis

Start date: 2022-03-31
Primary completion: 2024-10-15
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.